Clinical characteristics of diarrhea in 90 cases with COVID-19: A descriptive study
Background
The novel coronavirus disease (COVID-19) has spread worldwide. Herein, we aimed to clarify the epidemiological and clinical characteristics of patients presenting with diarrhea.
Methods
A descriptive design was adopted from Jan 10 to Feb 17, 2020. All the cases included were diagnosed with COVID-19 under the interim guidance of the WHO.
Results
912 patients with COVID-19 were admitted to hospital, in which, 90 cases (9.87%) presented with diarrhea. Among the 90 cases, 8 cases (9%) presented with diarrhea as the initial symptom, and 24%, 17%, and 24% of the patients complained of nausea, vomiting, and poor appetite, respectively. The most common fecal characteristics on admission were watery stool (64%) and mushy stool (28%). For the defecation frequency, 37% of the cases defecated over three times a day. The median time from illness onset to diarrhea was 3.0 days (IQR 0.0–5.0) and the median duration of diarrhea was 5.0 days (IQR 2.0–9.3).
Conclusion
Clinicians are required to promptly identify the patients with initial diarrhea symptoms and pay adequate attention to the nutrient requirements of the patients with diarrhea during hospitalization. Standardized management is also recommended for the discharge of the patients to avoid potential fecal-oral transmission.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
- 1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong YEarly transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382(13):1199–1207.[Google Scholar]
- 2. Fei Z., Ting Y., Ronghui DClinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 doi: 10.1016/S0140-6736(20)30566-3. published online March 12. ] [[Google Scholar]
- 3. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang JClinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061. doi: 10.1001/jama.2020.1585.] [[Google Scholar]
- 4. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu YClinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.[Google Scholar]
- 5. Chen N., Zhou M., Dong X., Qu J., Gong F., Han YEpidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–513.[Google Scholar]
- 6. Guan W.-J., Ni Z.-y., Hu Y.u., Liang W.-H., Ou C.-Q., He J.-XClinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.[Google Scholar]
- 7. Zhou Z., Zhao N., Shu Y., Han S., Chen B., Shu XEffect of gastrointestinal symptoms on patients infected with COVID-19. Gastroenterology. 2020 doi: 10.1053/j.gastro.2020.03.020.] [[Google Scholar]
- 8. Luo S., Zhang X., Xu HDon't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19) Clin Gastroenterol Hepatol. 2020;18(7):1636–1637.[Google Scholar]
- 9. Gu J., Han B., Wang JCOVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology. 2020;158(6):1518–1519.[Google Scholar]
- 10. Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce HFirst case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–936.[Google Scholar]
- 11. National Health Commission of China. New coronavirus pneumonia prevention and control program (seventh edn). Mar 4, 2020. http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml (in Chinese).
- 12. Chinese society of parenteral nutrition. Covid-19 enteral parenteral nutrition therapy for critically ill patients. Chinese J Med 2020;100(00):E009-E009, doi: 10.3760/cma.j.cn112137-20200212-00261 (in Chinese).
- 13. Shi HP, Xu HX, Li SY, et al. Committee of tumor nutrition and supportive therapy, Chinese association against cancer. Five-step therapy for malnutrition. J Tumor Metabolism Nutrition, 2015;2(1):29–33(in Chinese).
- 14. Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong XProlonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5(5):434–435.[Google Scholar]
- 15. Goh GK-M, Dunker AK, Foster JA, Uversky VN. Rigidity of the outer shell predicted by a protein intrinsic disorder model sheds light on the COVID-19 (Wuhan-2019-nCoV) infectivity. Biomolecules 2020;10:e331.
- 16. Bai Y., Yao L., Wei T., Tian F., Jin D.-Y., Chen L., Wang MPresumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406. doi: 10.1001/jama.2020.2565.] [[Google Scholar]
- 17. Lan L., Xu D., Ye G., Xia C., Wang S., Li Y., Xu HPositive RT-PCR test results in patients recovered from COVID-19. JAMA. 2020;323(15):1502. doi: 10.1001/jama.2020.2783.] [[Google Scholar]